Lipid Emulsion Type and Liver Function in Parenteral Nutrition Patients: A Retrospective Study of Patients and Prescribing Practices

被引:0
作者
Melendez, Marvick [1 ]
Mitchell, Ronelle [1 ]
Heredia, Hannah [1 ]
Lloyd, Jennifer [1 ]
Taliaferro, Jill [1 ]
Beveridge, Erin K. [1 ]
Ives, Stephen J. [2 ]
机构
[1] Optum Home Infus Serv, 8509 Benjamin Rd, Tampa, FL 33364 USA
[2] Skidmore Coll, Hlth & Human Physiol Sci, Saratoga Springs, NY 12866 USA
关键词
parenteral nutrition; liver function tests; intravenous lipid emulsions; LONG-TERM SURVIVAL;
D O I
10.3390/nu16162590
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Parenteral nutrition (PN) is a life-sustaining method to provide adequate nutrients to patients unable to receive oral or enteral nutrition. PN typically contains a mixture of macro- and micro-nutrients, although the lipid composition has been identified as a concern for liver disease. Therefore, the study of the intravenous lipid emulsion (ILE) prescribing practices in home-based PN (HPN) patients and whether differing lipid PN alters liver function tests (LFTs) is needed. Methods: A retrospective study of monthly LFTs from a random sample of 105 adult HPN patients in the U.S. over a 6-month period was conducted. Patients were receiving olive oil/soy oil (n = 53, Clinolipid), mixed ILE (n = 39, SMOF Lipid), soy oil (SO; n = 4, Intralipid), or none (n = 7). LFTs monitored were alkaline phosphatase (ALP), alanine transaminase (ALT), aspartate transaminase (AST), and total bilirubin (T Bili). Results: No differences were observed in baseline LFTs across groups (all, p > 0.25, eta(2) < 0.04), nor were there differences in age, body mass index, days of PN, or mean PN volume (all, p > 0.36, eta(2) < 0.05). There were no significant interactions between ILE type and time (all p > 0.64, eta(2)(p) < 0.03), no effect of ILE type (all p > 0.60, eta(2)(p) < 0.03), and no effect of time (all p > 0.69, eta(2)(p) < 0.01) in terms of LFTs. Average LFTs over six months were also not different between ILE types (all p > 0.30, eta(2) < 0.04). Conclusion: These findings suggested that patients were mostly prescribed mixed or ILE PN containing more than one lipid source and that differing ILEs in long-term HPN patients did not alter LFTs over a six-month period.
引用
收藏
页数:11
相关论文
共 22 条
  • [21] Current strategies for managing intestinal failure-associated liver disease
    Secor, Jordan D.
    Yu, Lumeng
    Tsikis, Savas
    Fligor, Scott
    Puder, Mark
    Gura, Kathleen M.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2021, 20 (03) : 307 - 319
  • [22] Steroidal Compounds in Commercial Parenteral Lipid Emulsions
    Xu, Zhidong
    Harvey, Kevin A.
    Pavlina, Thomas
    Dutot, Guy
    Hise, Mary
    Zaloga, Gary P.
    Siddiqui, Rafat A.
    [J]. NUTRIENTS, 2012, 4 (08): : 904 - 921